Nicotine Polacrilex Lozenge
Product Images NDC 72162-2266

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Nicotine Polacrilex (NDC 72162-2266). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig1 (Fig1)

This text provides a guide for using lozenges as a step-down method to quit smoking. It suggests taking one lozenge every 1-2 hours during the first week and then adjusting to one lozenge every 4-8 hours during the next stage. It also mentions a reminder for the 12-week mark after the quit date.*

FDA Label Image

Label (Lbl721622266)

This is a drug information leaflet for Nicotine Polacrlex Lozenges used as a stop smoking aid. The active ingredient in each lozenge is 2 mg of Nicotine Polacrlex. The leaflet provides instructions for use, warnings about the potential dangers of nicotine ingestion for children and pets, and information about the inactive ingredients in the lozenges. It also contains the NDC code for the product and information about the manufacturer, Bryant Ranch Prepack, Inc. from Burbank, CA.*

FDA Label Image

Pic1 (Pic1)

This text provides a list of important phone numbers to call for help with various health-related issues, including smoking cessation support. It includes contact information for the American Lung Association, American Cancer Society, American Heart Association, as well as the suggestion to reach out to a Quitting Buddy or a Friend who has Quit.*

FDA Label Image

Pic2 (Pic2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.